These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7331741)

  • 1. [Therapy of ventricular tachyarrhythmias refractory to lidocaine with propafenone (author's transl)].
    Laimer H; Glogar D; Zilcher H
    Acta Med Austriaca; 1981; 8(5):140-4. PubMed ID: 7331741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of recurrent ventricular tachycardias using oral propafenone].
    Cointe R; Lévy S; Metge M; Vrancea F; Labrunie P; Valeix B; Gérard R
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():59-62. PubMed ID: 3938260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indications and risks of anti-arrhythmia treatment with propafenone (author's transl)].
    Beck OA; Hochrein H
    Dtsch Med Wochenschr; 1978 Aug; 103(32):1261-5. PubMed ID: 78793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propafenone in the treatment of patients with malignant ventricular tachyarrhythmias.
    Kowey PR; Stohler JL; Friehling TD; Marinchak RA
    Can J Cardiol; 1991 May; 7(4):175-80. PubMed ID: 2070286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of Nifekalant hydrochloride for life-threatening ventricular tachyarrhythmias in patients with resistance to lidocaine: a study of patients with out-of-hospital cardiac arrest].
    Amino M; Yoshioka K; Iwata O; Fujikura H; Deguchi Y; Ban K; Shiina Y; Goto S; Handa S; Tanabe T; Nakagawa Y; Morita S; Iwase H; Yamamoto I; Inokuchi S; Marutani Y
    J Cardiol; 2003 Mar; 41(3):127-34. PubMed ID: 12674997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ventricular tachycardia--Effects of propafenon by intravenous route. Comparative study with lidocaine].
    Marino RL; Serufo JC; de Souza LS; Marino MA; Borges MZ; Rabelo RC; Bernardes Rde C; de Almeida RC; Rabelo W
    Arq Bras Cardiol; 1981 Jul; 37(1):67-72. PubMed ID: 6753799
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F; Grävinghoff L; Grütte E; Jüngst BK; Liersch R; Nomayo H; Puls I; Rautenburg HW; Schmaltz A; Schumacher G
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):154-7. PubMed ID: 4010670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative investigation of the antiarrhythmic effect of propafenone (Rytmonorm) and lidocaine in patients with ventricular arrhythmias during acute myocardial infarction.
    Rehnqvist N; Ericsson CG; Eriksson S; Olsson G; Svensson G
    Acta Med Scand; 1984; 216(5):525-30. PubMed ID: 6395642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report.
    Aguglia F; Gnecchi M; De Marzio P
    Int J Cardiol; 1985 Mar; 7(3):303-6. PubMed ID: 2579918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propafenone: noninvasive evaluation of efficacy.
    Podrid PJ; Cytryn R; Lown B
    Am J Cardiol; 1984 Nov; 54(9):53D-59D. PubMed ID: 6496369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epicardial, endocardial and transmural mapping in assessing electrophysiological effects of 14-C lidocaine and 14-C propafenone on activation times in experimental chronic myocardial infarction. Correlations with myocardial drugs concentrations.
    Naccarella FF; Agarwal JB; Weintraub WS; Bracchetti D; Helfant RH
    G Ital Cardiol; 1984 Oct; 14(10):825-9. PubMed ID: 6519392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propafenone therapy for ventricular tachycardia in the setting of congestive heart failure.
    Brodsky MA; Allen BJ; Abate D; Henry WL
    Am Heart J; 1985 Oct; 110(4):794-9. PubMed ID: 4050651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of ventricular tachycardia with propafenone. Parallel study of ventricular provocation tests].
    Faućhier JP; Rouesnel P; Cosnay P; Moquet B; Huguet R; Van Viet H; Balleh H
    Arch Mal Coeur Vaiss; 1987 Sep; 80(10):1523-31. PubMed ID: 3125812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous versus oral initial load of propafenone for conversion of recent-onset atrial fibrillation in the emergency room: a randomized trial.
    Madonia S; De Simone M; Brai G; Gozzo D; Gristina A; Luciano L; Maisano S; Migliore G; Mineo R; Muzzo MP; Nicchi F; Randazzo A; Raspanti G; Rotolo G; Russo A; Sagona F; Schirosa M; Spinello M; Stancampiano R; Geraci E
    Ital Heart J; 2000 Jul; 1(7):475-9. PubMed ID: 10933330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of a new anti-arrhythmic drug: propafenon. Short and long-term results].
    Ruipércz Abizanda JA; Campos Peris JV; García García J; Jaen Armand E; Ruiz Ros JA; Salas Nieto J; Rodríguez Ruiz P; Marco Quiles J; Martínez Jérez M; Pico Aracil F
    Arch Inst Cardiol Mex; 1981; 51(4):371-6. PubMed ID: 7337481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of new antiarrhythmic agents: experiences with propafenone.
    Furlanello F; Disertori M; Vergara G; Guarnerio M; Dal Forno P; Padrini R; Gobbato S; Ferrari M
    Int J Clin Pharmacol Res; 1983; 3(2):101-5. PubMed ID: 6679511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative studies of tocainide and propafenone in the treatment of ventricular arrhythmias].
    Gebhardt A; Schmuderer R; Hilpert P
    Arzneimittelforschung; 1984; 34(3):303-6. PubMed ID: 6428425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of ventricular arrhythmias by propafenone, a new antiarrhythmic agent, during acute myocardial infarction in the conscious dog. A comparative study with lidocaine.
    Karagueuzian HS; Fujimoto T; Katoh T; Peter T; McCullen A; Mandel WJ
    Circulation; 1982 Dec; 66(6):1190-8. PubMed ID: 7139897
    [No Abstract]   [Full Text] [Related]  

  • 20. Electrophysiologic effects and clinical efficacy of oral propafenone therapy in patients with ventricular tachycardia.
    Chilson DA; Heger JJ; Zipes DP; Browne KF; Prystowsky EN
    J Am Coll Cardiol; 1985 Jun; 5(6):1407-13. PubMed ID: 3889099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.